1. Home
  2. NBTB vs HCM Comparison

NBTB vs HCM Comparison

Compare NBTB & HCM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

NBTB

NBT Bancorp Inc.

HOLD

Current Price

$41.88

Market Cap

2.3B

Sector

Finance

ML Signal

HOLD

Logo HUTCHMED (China) Limited

HCM

HUTCHMED (China) Limited

N/A

Current Price

$14.15

Market Cap

2.6B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
NBTB
HCM
Founded
1856
2000
Country
United States
Hong Kong
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.3B
2.6B
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
NBTB
HCM
Price
$41.88
$14.15
Analyst Decision
Buy
Sell
Analyst Count
3
1
Target Price
$52.33
$13.75
AVG Volume (30 Days)
208.6K
28.1K
Earning Date
10-27-2025
08-07-2025
Dividend Yield
3.53%
N/A
EPS Growth
5.89
N/A
EPS
3.02
0.53
Revenue
$629,728,000.00
$602,197,000.00
Revenue This Year
$27.08
N/A
Revenue Next Year
$9.17
$15.54
P/E Ratio
$13.89
$5.26
Revenue Growth
16.88
N/A
52 Week Low
$37.31
$11.51
52 Week High
$52.44
$19.50

Technical Indicators

Market Signals
Indicator
NBTB
HCM
Relative Strength Index (RSI) 55.23 37.36
Support Level $40.80 $14.11
Resistance Level $42.58 $14.63
Average True Range (ATR) 0.97 0.26
MACD 0.12 -0.00
Stochastic Oscillator 71.45 26.31

Price Performance

Historical Comparison
NBTB
HCM

About NBTB NBT Bancorp Inc.

NBT Bancorp Inc is a financial holding company that operates through its subsidiaries. The company's principal sources of revenue include management fees and dividends it receives through its subsidiaries. Its business, predominantly conducted through NBT Bank, consists of providing commercial banking, retail banking, and wealth management services to customers in its market area, which includes upstate New York, northeastern Pennsylvania, southern New Hampshire, western Massachusetts, Vermont, southern Maine, and central and northwestern Connecticut. The company's reportable segments are Banking and Retirement Plan Administration. A majority of its revenue is generated from the Banking segment.

About HCM HUTCHMED (China) Limited

HUTCHMED (China) Ltd is an biopharmaceutical company engaged in the discovery, development, and commercialization of targeted therapies and immunotherapies for the treatment of cancer and immunological diseases. The company has a portfolio of several cancer drug candidates currently in clinical studies around the world and extensive commercial infrastructure in its home market of China. The company operates in two reportable segments Oncology/Immunology, and Other Ventures.

Share on Social Networks: